This article is more than 5 years old. Information may no longer be current.

VIDEO: SightGlass Vision details development of spectacles for myopia control

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

ORLANDO, Fla. – SightGlass Vision chief medical officer, Joe Rappon, OD, MS, FAAO, traced the development of the company’s spectacle lens technology to control myopia progression in a poster here at the American Academy of Optometry meeting and World Congress of Optometry.

One-year results of the CYPRESS study, which is evaluating the safety and efficacy of the SightGlass product vs. standard spectacle lenses are expected in the second quarter of 2020, Rappon said.

Disclosure: Rappon is employed by SightGlass Vision.